1 Introduction to Research & Analysis Reports 1.1 Human Insulin Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Human Insulin Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Human Insulin Overall Market Size 2.1 China Human Insulin Market Size: 2021 VS 2027 2.2 China Human Insulin Revenue, Prospects & Forecasts: 2016-2027 2.3 China Human Insulin Sales: 2016-2027 3 Company Landscape 3.1 Top Human Insulin Players in China Market 3.2 Top China Human Insulin Companies Ranked by Revenue 3.3 China Human Insulin Revenue by Companies 3.4 China Human Insulin Sales by Companies 3.5 China Human Insulin Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Human Insulin Companies in China Market, by Revenue in 2020 3.7 Manufacturers Human Insulin Product Type 3.8 Tier 1, Tier 2 and Tier 3 Human Insulin Players in China Market 3.8.1 List of Tier 1 Human Insulin Companies in China 3.8.2 List of Tier 2 and Tier 3 Human Insulin Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Human Insulin Market Size Markets, 2021 & 2027 4.1.2 Insulin Analogs and Biosimilars 4.1.3 Human Insulin Biologics 4.2 By Type - China Human Insulin Revenue & Forecasts 4.2.1 By Type - China Human Insulin Revenue, 2016-2021 4.2.2 By Type - China Human Insulin Revenue, 2022-2027 4.2.3 By Type - China Human Insulin Revenue Market Share, 2016-2027 4.3 By Type - China Human Insulin Sales & Forecasts 4.3.1 By Type - China Human Insulin Sales, 2016-2021 4.3.2 By Type - China Human Insulin Sales, 2022-2027 4.3.3 By Type - China Human Insulin Sales Market Share, 2016-2027 4.4 By Type - China Human Insulin Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Human Insulin Market Size, 2021 & 2027 5.1.2 Short Acting 5.1.3 Intermediate Acting 5.1.4 Long Acting 5.1.5 Pre-Mix Insulin 5.2 By Application - China Human Insulin Revenue & Forecasts 5.2.1 By Application - China Human Insulin Revenue, 2016-2021 5.2.2 By Application - China Human Insulin Revenue, 2022-2027 5.2.3 By Application - China Human Insulin Revenue Market Share, 2016-2027 5.3 By Application - China Human Insulin Sales & Forecasts 5.3.1 By Application - China Human Insulin Sales, 2016-2021 5.3.2 By Application - China Human Insulin Sales, 2022-2027 5.3.3 By Application - China Human Insulin Sales Market Share, 2016-2027 5.4 By Application - China Human Insulin Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 B. Braun 6.1.1 B. Braun Corporation Information 6.1.2 B. Braun Overview 6.1.3 B. Braun Human Insulin Sales and Revenue in China Market (2016-2021) 6.1.4 B. Braun Human Insulin Product Description 6.1.5 B. Braun Recent Developments 6.2 Becton, Dickinson 6.2.1 Becton, Dickinson Corporation Information 6.2.2 Becton, Dickinson Overview 6.2.3 Becton, Dickinson Human Insulin Sales and Revenue in China Market (2016-2021) 6.2.4 Becton, Dickinson Human Insulin Product Description 6.2.5 Becton, Dickinson Recent Developments 6.3 Biocon 6.3.1 Biocon Corporation Information 6.3.2 Biocon Overview 6.3.3 Biocon Human Insulin Sales and Revenue in China Market (2016-2021) 6.3.4 Biocon Human Insulin Product Description 6.3.5 Biocon Recent Developments 6.4 Biodel 6.4.1 Biodel Corporation Information 6.4.2 Biodel Overview 6.4.3 Biodel Human Insulin Sales and Revenue in China Market (2016-2021) 6.4.4 Biodel Human Insulin Product Description 6.4.5 Biodel Recent Developments 6.5 ELI Lilly 6.5.1 ELI Lilly Corporation Information 6.5.2 ELI Lilly Overview 6.5.3 ELI Lilly Human Insulin Sales and Revenue in China Market (2016-2021) 6.5.4 ELI Lilly Human Insulin Product Description 6.5.5 ELI Lilly Recent Developments 6.6 Julphar 6.6.1 Julphar Corporation Information 6.6.2 Julphar Overview 6.6.3 Julphar Human Insulin Sales and Revenue in China Market (2016-2021) 6.6.4 Julphar Human Insulin Product Description 6.6.5 Julphar Recent Developments 6.7 NOVO Nordisk 6.7.1 NOVO Nordisk Corporation Information 6.7.2 NOVO Nordisk Overview 6.7.3 NOVO Nordisk Human Insulin Sales and Revenue in China Market (2016-2021) 6.7.4 NOVO Nordisk Human Insulin Product Description 6.7.5 NOVO Nordisk Recent Developments 6.8 Sanofi 6.8.1 Sanofi Corporation Information 6.8.2 Sanofi Overview 6.8.3 Sanofi Human Insulin Sales and Revenue in China Market (2016-2021) 6.8.4 Sanofi Human Insulin Product Description 6.8.5 Sanofi Recent Developments 6.9 Wockhardt 6.9.1 Wockhardt Corporation Information 6.9.2 Wockhardt Overview 6.9.3 Wockhardt Human Insulin Sales and Revenue in China Market (2016-2021) 6.9.4 Wockhardt Human Insulin Product Description 6.9.5 Wockhardt Recent Developments 6.10 Ypsomed 6.10.1 Ypsomed Corporation Information 6.10.2 Ypsomed Overview 6.10.3 Ypsomed Human Insulin Sales and Revenue in China Market (2016-2021) 6.10.4 Ypsomed Human Insulin Product Description 6.10.5 Ypsomed Recent Developments 7 China Human Insulin Production Capacity, Analysis 7.1 China Human Insulin Production Capacity, 2016-2027 7.2 Human Insulin Production Capacity of Key Manufacturers in China Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Human Insulin Supply Chain Analysis 9.1 Human Insulin Industry Value Chain 9.2 Human Insulin Upstream Market 9.3 Human Insulin Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Human Insulin Distributors and Sales Agents in China Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Human Insulin in China Market Table 2. Top Human Insulin Players in China Market, Ranking by Revenue (2019) Table 3. China Human Insulin Revenue by Companies, (US$, Mn), 2016-2021 Table 4. China Human Insulin Revenue Share by Companies, 2016-2021 Table 5. China Human Insulin Sales by Companies, (K Doses), 2016-2021 Table 6. China Human Insulin Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Human Insulin Price (2016-2021) & (USD/Dose) Table 8. Manufacturers Human Insulin Product Type Table 9. List of Tier 1 Human Insulin Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Human Insulin Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Insulin Analogs and Biosimilars Table 12. Major Manufacturers of Human Insulin Biologics Table 13. By Type – China Human Insulin Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - China Human Insulin Revenue (US$, Mn), 2016-2021 Table 15. By Type - China Human Insulin Revenue (US$, Mn), 2022-2027 Table 16. By Type - China Human Insulin Sales (K Doses), 2016-2021 Table 17. By Type - China Human Insulin Sales (K Doses), 2022-2027 Table 18. By Application – China Human Insulin Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - China Human Insulin Revenue (US$, Mn), 2016-2021 Table 20. By Application - China Human Insulin Revenue (US$, Mn), 2022-2027 Table 21. By Application - China Human Insulin Sales (K Doses), 2016-2021 Table 22. By Application - China Human Insulin Sales (K Doses), 2022-2027 Table 23. B. Braun Corporation Information Table 24. B. Braun Description and Major Businesses Table 25. B. Braun Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 26. B. Braun Human Insulin Product Table 27. B. Braun Recent Developments Table 28. Becton, Dickinson Corporation Information Table 29. Becton, Dickinson Description and Major Businesses Table 30. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 31. Becton, Dickinson Human Insulin Product Table 32. Becton, Dickinson Recent Developments Table 33. Biocon Corporation Information Table 34. Biocon Description and Major Businesses Table 35. Biocon Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 36. Biocon Human Insulin Product Table 37. Biocon Recent Developments Table 38. Biodel Corporation Information Table 39. Biodel Description and Major Businesses Table 40. Biodel Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 41. Biodel Human Insulin Product Table 42. Biodel Recent Developments Table 43. ELI Lilly Corporation Information Table 44. ELI Lilly Description and Major Businesses Table 45. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 46. ELI Lilly Human Insulin Product Table 47. ELI Lilly Recent Developments Table 48. Julphar Corporation Information Table 49. Julphar Description and Major Businesses Table 50. Julphar Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 51. Julphar Human Insulin Product Table 52. Julphar Recent Developments Table 53. NOVO Nordisk Corporation Information Table 54. NOVO Nordisk Description and Major Businesses Table 55. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 56. NOVO Nordisk Human Insulin Product Table 57. NOVO Nordisk Recent Developments Table 58. Sanofi Corporation Information Table 59. Sanofi Description and Major Businesses Table 60. Sanofi Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 61. Sanofi Human Insulin Product Table 62. Sanofi Recent Developments Table 63. Wockhardt Corporation Information Table 64. Wockhardt Description and Major Businesses Table 65. Wockhardt Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 66. Wockhardt Human Insulin Product Table 67. Wockhardt Recent Developments Table 68. Ypsomed Corporation Information Table 69. Ypsomed Description and Major Businesses Table 70. Ypsomed Human Insulin Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 71. Ypsomed Human Insulin Product Table 72. Ypsomed Recent Developments Table 73. Human Insulin Production Capacity (K Doses) of Key Manufacturers in China Market, 2019-2021 (K Doses) Table 74. China Human Insulin Capacity Market Share of Key Manufacturers, 2019-2021 Table 75. Human Insulin Market Opportunities & Trends in China Market Table 76. Human Insulin Market Drivers in China Market Table 77. Human Insulin Market Restraints in China Market Table 78. Human Insulin Raw Materials Table 79. Human Insulin Raw Materials Suppliers in China Market Table 80. Typical Human Insulin Downstream Table 81. Human Insulin Downstream Clients in China Market Table 82. Human Insulin Distributors and Sales Agents in China Market List of Figures Figure 1. Human Insulin Product Picture Figure 2. Human Insulin Segment by Type Figure 3. Human Insulin Segment by Application Figure 4. China Human Insulin Market Overview: 2020 Figure 5. China Human Insulin Market Size: 2021 VS 2027 (US$, Mn) Figure 6. China Human Insulin Revenue, 2016-2027 (US$, Mn) Figure 7. Human Insulin Sales in China Market: 2016-2027 (K Doses) Figure 8. The Top 3 and 5 Players Market Share by Human Insulin Revenue in 2020 Figure 9. Insulin Analogs and Biosimilars Product Picture Figure 10. Human Insulin Biologics Product Picture Figure 11. By Type - China Human Insulin Sales Market Share, 2016-2027 Figure 12. By Type - China Human Insulin Revenue Market Share, 2016-2027 Figure 13. By Type - China Human Insulin Price (USD/Dose), 2016-2027 Figure 14. Short Acting Figure 15. Intermediate Acting Figure 16. Long Acting Figure 17. Pre-Mix Insulin Figure 18. By Application - China Human Insulin Sales Market Share, 2016-2027 Figure 19. By Application - China Human Insulin Revenue Market Share, 2016-2027 Figure 20. By Application - China Human Insulin Price (USD/Dose), 2016-2027 Figure 21. B. Braun Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Becton, Dickinson Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Biocon Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Biodel Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. ELI Lilly Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Julphar Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. NOVO Nordisk Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Sanofi Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Wockhardt Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Ypsomed Human Insulin Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. China Human Insulin Production Capacity (K Doses), 2016-2027 Figure 32. Human Insulin Industry Value Chain Figure 33. Marketing Channels

B. Braun Becton, Dickinson Biocon Biodel ELI Lilly Julphar NOVO Nordisk Sanofi Wockhardt Ypsomed